HK1204773A1 - Pyrazole derivative and use thereof for medical purposes - Google Patents

Pyrazole derivative and use thereof for medical purposes

Info

Publication number
HK1204773A1
HK1204773A1 HK15105374.8A HK15105374A HK1204773A1 HK 1204773 A1 HK1204773 A1 HK 1204773A1 HK 15105374 A HK15105374 A HK 15105374A HK 1204773 A1 HK1204773 A1 HK 1204773A1
Authority
HK
Hong Kong
Prior art keywords
medical purposes
pyrazole derivative
pyrazole
derivative
medical
Prior art date
Application number
HK15105374.8A
Other languages
English (en)
Chinese (zh)
Inventor
Masayuki Isaji
Masaaki Takemura
Hidetoshi Isawa
Yukihiko Hotei
Itaru Miyashita
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of HK1204773A1 publication Critical patent/HK1204773A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15105374.8A 2012-05-07 2015-06-05 Pyrazole derivative and use thereof for medical purposes HK1204773A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012105847 2012-05-07
PCT/JP2013/062755 WO2013168671A1 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途

Publications (1)

Publication Number Publication Date
HK1204773A1 true HK1204773A1 (en) 2015-12-04

Family

ID=49550709

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105374.8A HK1204773A1 (en) 2012-05-07 2015-06-05 Pyrazole derivative and use thereof for medical purposes

Country Status (16)

Country Link
US (2) US9273085B2 (xx)
EP (1) EP2848254B1 (xx)
JP (2) JP5663699B2 (xx)
KR (1) KR101868991B1 (xx)
CN (1) CN104284665B (xx)
AU (1) AU2013258566B2 (xx)
BR (1) BR112014027841B1 (xx)
CA (1) CA2872002C (xx)
DK (1) DK2848254T3 (xx)
ES (1) ES2601127T3 (xx)
HK (1) HK1204773A1 (xx)
MX (1) MX359988B (xx)
PL (1) PL2848254T3 (xx)
PT (1) PT2848254T (xx)
RU (1) RU2602739C2 (xx)
WO (1) WO2013168671A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013010157B1 (pt) 2010-11-08 2020-02-04 Albireo Ab iinibidores do ibat, seus usos, e composição e combinações farmacêuticas
US9273085B2 (en) * 2012-05-07 2016-03-01 Kissei Pharmaceutical Co., Ltd. Pyrazole derivative and use thereof for medical purposes
RU2648467C2 (ru) 2013-02-04 2018-03-26 Тайсо Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое лекарственное средство для лечения запора
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
JP6581082B2 (ja) * 2014-06-25 2019-09-25 Eaファーマ株式会社 固形製剤及びその安定化方法
US11596644B2 (en) 2018-03-28 2023-03-07 Avolynt Method for treating post-prandial hypoglycemia
ES2942443T3 (es) 2018-06-05 2023-06-01 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares
CN112262130A (zh) 2018-06-20 2021-01-22 阿尔比里奥公司 奥德昔巴特的结晶修饰物
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
JP2023504644A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
PL4069360T3 (pl) 2019-12-04 2024-04-29 Albireo Ab Związki benzotio(di)azepinowe i ich zastosowanie jako modulatory kwasów żółciowych
EP4188541A1 (en) 2020-08-03 2023-06-07 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
AU2021379076A1 (en) 2020-11-12 2023-06-08 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
AU2021390172A1 (en) 2020-12-04 2023-06-22 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
CN101511840A (zh) * 2006-04-26 2009-08-19 吉宁特有限公司 磷酸肌醇3-激酶抑制剂化合物及其使用方法
CN101910189B (zh) * 2007-12-27 2013-06-19 橘生药品工业株式会社 吡唑衍生物的单癸二酸盐
ES2385185T3 (es) 2008-04-16 2012-07-19 Kissei Pharmaceutical Co., Ltd. Hemifumarato de un derivado de pirazol
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
US9273085B2 (en) * 2012-05-07 2016-03-01 Kissei Pharmaceutical Co., Ltd. Pyrazole derivative and use thereof for medical purposes

Also Published As

Publication number Publication date
BR112014027841A8 (pt) 2021-09-28
EP2848254A4 (en) 2015-07-15
KR101868991B1 (ko) 2018-06-19
KR20150013671A (ko) 2015-02-05
BR112014027841B1 (pt) 2022-08-09
AU2013258566B2 (en) 2017-03-16
US20160129031A1 (en) 2016-05-12
EP2848254A1 (en) 2015-03-18
JP6105546B2 (ja) 2017-03-29
WO2013168671A1 (ja) 2013-11-14
US20150141631A1 (en) 2015-05-21
CN104284665B (zh) 2016-11-16
AU2013258566A1 (en) 2014-11-27
MX359988B (es) 2018-10-18
DK2848254T3 (en) 2016-10-31
PT2848254T (pt) 2016-10-05
JP5663699B2 (ja) 2015-02-04
US9273085B2 (en) 2016-03-01
US9694027B2 (en) 2017-07-04
JP2015083580A (ja) 2015-04-30
MX2014013696A (es) 2015-02-05
BR112014027841A2 (pt) 2017-06-27
CA2872002A1 (en) 2013-11-14
RU2602739C2 (ru) 2016-11-20
CA2872002C (en) 2019-01-15
RU2014149181A (ru) 2016-06-27
ES2601127T3 (es) 2017-02-14
JPWO2013168671A1 (ja) 2016-01-07
CN104284665A (zh) 2015-01-14
PL2848254T3 (pl) 2017-03-31
EP2848254B1 (en) 2016-08-03

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
HK1204773A1 (en) Pyrazole derivative and use thereof for medical purposes
HK1204253A1 (en) Magnetometer for medical use
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
HK1202290A1 (en) Pyrazole compound and use thereof for medical purposes
EP2842945A4 (en) SULFONAMIDE DERIVATIVE AND MEDICAL USE THEREOF
EP2740728A4 (en) URACIL DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
EP2832724A4 (en) NIPETIC ACID DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
PL2656843T3 (pl) Estry bendamustyny i związki pokrewne i ich medyczne zastosowanie
GB201215502D0 (en) Medical use
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
GB2502895B (en) Trouser Braces and Adaptor
GB201216381D0 (en) New compounds and medical uses
GB201208970D0 (en) New compounds and medical uses
HUE043268T2 (hu) Pirazolvegyületek és azok gyógyászati alkalmazása